Table of Contents for the Digital Edition of BioPharm International - April 2009 BioPharm International - April 2009 Contents From the Editor Global News Regulatory Beat Perspectives on Outsourcing Expression Systems Disposables Advisor Burrill on Biotech Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients A Risk-Based Approach to Deviation Management Funding Biodefense Vaccine Development New Technology Showcase Spotlight on: Fermentation and Cell Culture Classifieds Advertisers, Events Calendar Final Word BioPharm International - April 2009 BioPharm International - April 2009 - (Page BB1) BioPharm International - April 2009 - (Page BB2) BioPharm International - April 2009 - BioPharm International - April 2009 (Page Cover1) BioPharm International - April 2009 - BioPharm International - April 2009 (Page Cover2) BioPharm International - April 2009 - BioPharm International - April 2009 (Page 3) BioPharm International - April 2009 - Contents (Page 4) BioPharm International - April 2009 - Contents (Page 5) BioPharm International - April 2009 - Contents (Page 6) BioPharm International - April 2009 - Contents (Page 7) BioPharm International - April 2009 - Contents (Page 8) BioPharm International - April 2009 - Contents (Page 9) BioPharm International - April 2009 - From the Editor (Page 10) BioPharm International - April 2009 - From the Editor (Page 11) BioPharm International - April 2009 - Global News (Page 12) BioPharm International - April 2009 - Global News (Page 13) BioPharm International - April 2009 - Global News (Page 14) BioPharm International - April 2009 - Global News (Page 15) BioPharm International - April 2009 - Global News (Page 16) BioPharm International - April 2009 - Global News (Page 17) BioPharm International - April 2009 - Regulatory Beat (Page 18) BioPharm International - April 2009 - Regulatory Beat (Page 19) BioPharm International - April 2009 - Regulatory Beat (Page 20) BioPharm International - April 2009 - Regulatory Beat (Page 21) BioPharm International - April 2009 - Perspectives on Outsourcing (Page 22) BioPharm International - April 2009 - Perspectives on Outsourcing (Page 23) BioPharm International - April 2009 - Perspectives on Outsourcing (Page 24) BioPharm International - April 2009 - Perspectives on Outsourcing (Page 25) BioPharm International - April 2009 - Expression Systems (Page 26) BioPharm International - April 2009 - Expression Systems (Page 27) BioPharm International - April 2009 - Disposables Advisor (Page 28) BioPharm International - April 2009 - Disposables Advisor (Page 29) BioPharm International - April 2009 - Disposables Advisor (Page 30) BioPharm International - April 2009 - Disposables Advisor (Page 31) BioPharm International - April 2009 - Disposables Advisor (Page 32) BioPharm International - April 2009 - Disposables Advisor (Page 33) BioPharm International - April 2009 - Burrill on Biotech (Page 34) BioPharm International - April 2009 - Burrill on Biotech (Page 35) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 36) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 37) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 38) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 39) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 40) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 41) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 42) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 43) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 44) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 45) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 46) BioPharm International - April 2009 - Opalescence of an IgG1 Monoclonal Antibody Formulation is Mediated by Ionic Strength and Excipients (Page 47) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 48) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 49) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 50) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 51) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 52) BioPharm International - April 2009 - A Risk-Based Approach to Deviation Management (Page 53) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 54) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 55) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 56) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 57) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 58) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 59) BioPharm International - April 2009 - Funding Biodefense Vaccine Development (Page 60) BioPharm International - April 2009 - New Technology Showcase (Page 61) BioPharm International - April 2009 - Spotlight on: Fermentation and Cell Culture (Page 62) BioPharm International - April 2009 - Classifieds (Page 63) BioPharm International - April 2009 - Classifieds (Page 64) BioPharm International - April 2009 - Advertisers, Events Calendar (Page 65) BioPharm International - April 2009 - Final Word (Page 66) BioPharm International - April 2009 - Final Word (Page Cover3) BioPharm International - April 2009 - Final Word (Page Cover4) http://digital.findpharma.com/nxtbooks/advanstar/biopharm0112 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1211 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1211_v2 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1111_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm1111 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1011 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1011_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0911 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0911_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0811 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0811_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0711 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0611 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0511 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0511_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0411 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0411_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0311 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0311_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0211 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0211_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm0111 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0111_supp http://digital.findpharma.com/nxtbooks/advanstar/biopharm1210 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1110 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1110_supplement http://digital.findpharma.com/nxtbooks/advanstar/biopharm1010 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1010_supplement http://digital.findpharma.com/nxtbooks/advanstar/biopharm0910 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0910_bg http://digital.findpharma.com/nxtbooks/advanstar/biopharm0810 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0710 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0810_supplement http://digital.findpharma.com/nxtbooks/advanstar/biopharm0610 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0610_supplement http://digital.findpharma.com/nxtbooks/advanstar/biopharm0510 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0410 http://digital.findpharma.com/nxtbooks/advanstar/Biopharm0310 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0210 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0110 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1209 http://www.nxtbook.com/nxtbooks/advanstar/biopharm_mediakit2010 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1109 http://digital.findpharma.com/nxtbooks/advanstar/biopharm1009 http://digital.findpharma.com/nxtbooks/advanstar/bp1009_sartorius http://digital.findpharma.com/nxtbooks/advanstar/biopharm0909 http://digital.findpharma.com/nxtbooks/advanstar/bp0909_bg http://digital.findpharma.com/nxtbooks/advanstar/bp0809 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0709 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0609 http://digital.findpharma.com/nxtbooks/advanstar/biopharm0509 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0409 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0309 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0209 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0109 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1208 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1108 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1008 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0908 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0808 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0708 http://www.nxtbook.com/nxtbooks/advanstar/reprint_biopharm_novozymes_49286013 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0608 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0508 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0408 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0308 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0208 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0108 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1207 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1107 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1007 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1007_supplement http://www.nxtbook.com/nxtbooks/advanstar/biopharm0907 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0807 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0707 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0607 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0507 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0407 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0307 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0207 http://www.nxtbook.com/nxtbooks/advanstar/biopharm0107 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1206 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1106 http://www.nxtbook.com/nxtbooks/advanstar/biopharm1006 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.